sivelestat has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albeck, A; Khalfin, B; Lichtenstein, A; Nathan, I | 1 |
| Angelos, MG; Aune, SE; Khan, M; Kuppusamy, ML; Kuppusamy, P; Yeh, ST | 1 |
2 other study(ies) available for sivelestat and Myocardial Infarction
| Article | Year |
|---|---|
Targeting Necrosis: Elastase-like Protease Inhibitors Curtail Necrotic Cell Death Both
Topics: Animals; Brain Injuries, Traumatic; Cell Death; Chemical and Drug Induced Liver Injury; High-Throughput Screening Assays; Humans; Mice, Inbred BALB C; Mice, Inbred C57BL; Myocardial Infarction; Necroptosis; Necrosis; Pancreatic Elastase; Protease Inhibitors; RNA, Small Interfering; U937 Cells | 2021 |
Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion.
Topics: Animals; Aorta; Cardiotonic Agents; Cattle; Coronary Circulation; Creatine Kinase; Electron Spin Resonance Spectroscopy; Endothelial Cells; Glycine; Heart Ventricles; In Vitro Techniques; Male; Models, Cardiovascular; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfonamides; Superoxides; Vasoconstriction; Ventricular Function, Left | 2013 |